It seems like you are using a older browser so kindly update your browser for better experience

For Investors

Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
Share Page
Share Page
E-mail AlertsE-mail Alerts
IR ContactsIR Contacts
Financial Tear SheetFinancial Tear Sheet
Corporate Profile
Stryker is one of the world’s leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world.
Recent NewsMore >>
07/21/14Stryker Declares a $0.305 Quarterly Dividend
Kalamazoo, Michigan - July 21, 2014- Stryker Corporation (NYSE:SYK) announced that its Board of Directors has maintained a dividend consistent with that of the prior quarter, by declaring a quarterly dividend of $0.305 per share payable on October 31, 2014, to shareholders of record at the close of business on September 30, 2014. This represents an increase of 15% compared to the prior year.  Stryker is one of the world's leading medical technology companies and together with our customers, we a... 
07/18/14Stryker to Host Analyst Meeting
Kalamazoo, Michigan - July 18, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host an Analyst Meeting on Wednesday, September 17, 2014, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. Kevin Lobo, President and Chief Executive Officer, will host the meeting with presentations by leaders of the Company's key business units.            A simultaneous webcast of the meeting will be available on Stryker's website at via the Investor page. The webcast will be archived o... 
07/17/14Stryker Reports Second Quarter 2014 Results and 2014 Outlook
Kalamazoo, Michigan - July 17, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2014:       Net sales grew 6.8% to $2.4 billion        ·     Reconstructive                                   6.5%·     MedSurg                                            8.8%·     Neurotechnology and Spine              3.8%      Reported diluted net earnings per share unchanged at $0.56      Adjusted diluted net earnings per share(1) increased 1% to $1.08                &qu... 
Upcoming EventsMore >>
09/17/14 2:30 p.m. ET
Stryker Analyst Meeting
Webcast ImageWebcast - Replay
Q2 2014 Stryker Earnings Conference Call
07/17/14 at 4:30 p.m. ET
Q2 2014 Stryker Earnings Conference Call
Thursday, July 17, 2014 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Stock Quote
SYK (common stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Down 0.57 (0.69%)
Data as of 07/21/2014 4:00 p.m. ET
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Featured Reports
Download Documentation View the Notice and Proxy Statement
Download Documentation 2013 Online Annual Review (Print Friendly)
Download Documentation 2013 Annual Review (PDF)
Download Documentation 2013 Annual Report on Form 10-K (PDF)
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Stryker posts new information to the site. Just enter your e-mail address and click Submit.